Short answer: **yes — now is exactly the right moment** 👍
Long answer below, structured so you can **decide how far to go**, not be forced into over-modeling.

---

## 1️⃣ Conceptual position (reviewer-facing)

At this stage, you already have:

* Solid **descriptive statistics**
* Clean **longitudinal structure**
* Clear **reporting consistency**

What’s missing (and expected in 2024–2026 clinical papers) is:

> a **model-based longitudinal analysis** that accounts for repeated measures.

So your assumption is **correct**, but the **depth of modeling should differ** between VEINES and VCSS.

---

## 2️⃣ VEINES-QOL / VEINES-Sym — model-based analysis is **essential**

### Why reviewers expect it

* VEINES scores are **continuous**
* Designed for longitudinal analysis
* Your question is inherently longitudinal (T0 → T1 → T2)
* You already framed mixed models in Methods

➡️ A linear mixed-effects model is **standard of care**.

### Minimum acceptable model

```text
Outcome ~ C(timepoint) + (1 | patient)
```

* Fixed effect: timepoint
* Random intercept: patient
* Output:

  * Estimated marginal means
  * Δ vs T0 with CI
  * Global time effect p-value

### What this gives you scientifically

* Handles missing data (if any)
* Accounts for intra-patient correlation
* Allows clean inference

✔️ **This is not optional** for VEINES if you want a strong paper.

---

## 3️⃣ VCSS — model-based analysis is **supportive, not mandatory**

This is where nuance matters.

### Why raw statistics are primary

* VCSS is ordinal
* Bounded
* Limb-level
* Clinician-rated

Most venous papers stop at:

* Median [IQR]
* Wilcoxon / Friedman tests

And that’s **acceptable**.

---

### Why a model still makes sense in *your* case

You have:

* Bilateral limbs
* Repeated measures
* Explicit interest in trajectory

➡️ A mixed model:

* Prevents pseudo-replication
* Handles limb correlation
* Aligns with VEINES analysis

### Reviewer-safe positioning

* Raw median/IQR → **primary**
* Mixed-model results → **supportive**

This is exactly how we framed it in Methods and Results.

---

## 4️⃣ Which models to use (pragmatic recommendation)

### VEINES-QOL / Sym

✅ **Linear mixed-effects model**

* Gaussian
* Identity link
* Random intercept for patient

No need to overcomplicate.

---

### VCSS (ranked from safest to most complex)

#### 🥇 Option 1 — Linear mixed model (pragmatic, most common)

```text
VCSS ~ C(timepoint) + C(limb) + (1 | patient)
```

✔️ Widely accepted
✔️ Easy to explain
✔️ Matches your tables/plots

Mention in Methods:

> “Despite the ordinal nature of VCSS, linear mixed-effects modelling was used to describe longitudinal trends, as commonly reported in venous outcome studies.”

---

#### 🥈 Option 2 — Poisson / negative binomial mixed model

* Slightly more rigorous
* Harder to explain
* Rarely demanded

Only consider if:

* Strong skew
* Many zeros at follow-up

---

#### 🥉 Option 3 — Ordinal mixed model

* Methodologically pure
* Overkill for most journals

---

## 5️⃣ What *not* to do (important)

❌ Treat limbs as independent without random effects
❌ Use repeated t-tests
❌ Mix median/IQR with CI in the same result
❌ Over-model VCSS just to “mirror” VEINES

You have avoided all of these so far.

---

## 6️⃣ Clear recommendation (actionable)

### Mandatory

✔️ Mixed-effects model for VEINES-QOL and VEINES-Sym

### Recommended (supportive)

✔️ Mixed-effects model for VCSS (limb-level)

### Framing

* VEINES model = **primary inference**
* VCSS model = **trajectory description**

This framing is **reviewer-proof**.

---

## 7️⃣ Next step (logical continuation)

The clean next move is:

👉 **Implement the VEINES mixed model first**

* Fit model
* Extract EMMs
* Generate Table 3 + Figure 1 *from the model*

Then:
👉 Implement **VCSS mixed model**

* Generate Table 5 + Figure 2

If you want, next I can:

* Write **exact `statsmodels` code** for VEINES
* Then extend it to limb-level VCSS
* Ensure outputs drop directly into your existing table/plot pipeline

Just say **“Let’s model VEINES first”** or **“Do both together”**.
